A Neonatal Case of Infantile Malignant Osteopetrosis Presenting with Thrombocytopenia and Hypotonicity: A Novel Mutation in Chloride Voltage-Gated Channel 7 Gene
Open Access
- 1 January 2022
- journal article
- research article
- Published by Kare Publishing in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
- Vol. 56 (1) , 161-165
Abstract
Autosomal recessive osteopetrosis is also known as infantile malignant osteopetrosis (IMO). The clinical course is often serious and if left untreated, it is fatal in the 1st year of life. Diagnosis is challenging and often delayed or misdiagnosed. Herein, we present an infant girl who was diagnosed with IMO during evaluations for her hypotonicity and thrombocytopenia. A novel mutation of the chloride voltage-gated channel 7 (CLCN7) gene was also reported. A 10-day-old female patient was referred to our hospital for evaluation of hypotonicity. Her physical examination was normal, other than hypotonicity. Laboratory analysis revealed thrombocytopenia and hypocalcemia. In the progress, while she was followed in outpatient clinic, hepatosplenomegaly was detected at the age of 3 months. IMO was suspected with the findings of hepatosplenomegaly, cytopenia, hypocalcemia, difficulty of obtaining bone marrow, peripheral smear findings, and hearing loss. The X-ray of the bones was consistent with IMO. A novel pathogenic homozygous c.1 504>T (p.Arg 502Trp) mutation in CLCN7 gene was revealed. IMO is a rare disorder and it is important to differentiate this entity for better clinical outcome. The presence of neurological and hematological findings, organomegaly, hearing loss, and vision disorders must attract attention to IMO.Keywords
This publication has 11 references indexed in Scilit:
- Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosisMolecular Medicine Reports, 2019
- One Disease, Many Genes: Implications for the Treatment of OsteopetrosesFrontiers in Endocrinology, 2019
- Novel CLCN7 compound heterozygous mutations in intermediate autosomal recessive osteopetrosisHuman Genome Variation, 2017
- Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working GroupThe Journal of Clinical Endocrinology & Metabolism, 2017
- A novel mutation and a known mutation in the CLCN7 gene associated with relatively stable infantile malignant osteopetrosis in a Chinese patientGene, 2016
- Radiologic resolution of malignant infantile osteopetrosis skeletal changes following hematopoietic stem cell transplantationPediatric Blood & Cancer, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Osteopetrosis: genetics, treatment and new insights into osteoclast functionNature Reviews Endocrinology, 2013
- Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT reportBone Marrow Transplantation, 2003
- GeneReviews®1993